Damage of human renal glomerular endothelial cells (HRGECs) of the kidney represents the linchpin in the pathogenesis of the hemolytic uremic syndrome caused by Shiga toxins of enterohemorrhagic Escherichia coli (EHEC). We performed a comprehensive structural analysis of the Stx-receptor glycosphingolipids (GSLs) globotriaosylceramide (Gb3Cer, Galα4Galβ4Glcβ1Cer) and globotetraosylceramide (Gb4Cer, GalNAcβ3Galα4Galβ4Glcβ1Cer) and their distribution in lipid raft analog detergent-resistant membranes (DRMs) and nonDRMs prepared from primary HRGECs. Predominant receptor lipoforms were Gb3Cer and Gb4Cer with Cer (d18:1, C16:0), Cer (d18:1, C22:0) and Cer (d18:1, C24:1/C24:0). Stx-receptor GSLs co-distribute with sphingomyelin (SM) and cholesterol as well as flotillin-2 in DRMs, representing the liquid-ordered membrane phase and indicating lipid raft association. Lyso-phosphatidylcholine (lyso-PC) was identified as a nonDRM marker phospholipid of the liquid-disordered membrane phase. Exposure of primary HRGECs to the ceramide analogon D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) reduced total Gb3Cer and Gb4Cer content, roughly calculated from two biological replicates, down to half and quarter of its primordial content, respectively, but strengthened their prevalence and cholesterol preponderance in DRMs. At the same time, the distribution of PC, SM and lyso-PC to subcellular membrane fractions remained unaffected by D-PDMP treatment. Defining the GSL composition and precise microdomain structures of primary HRGECs may help to develop novel therapeutic options to combat life-threatening EHEC infections.
Introduction
The glomerulus represents a highly structured filtration unit of the kidney, composed of glomerular endothelial cells, mesangial cells, podocytes and parietal epithelial cells (Schell et al. 2014) . Glomerular endothelial cells represent highly specialized cells and are unique among other endothelial cells, largely owing to their key role in filtration of blood performed by the kidney (Fogo and Kon 2010) . Injury of glomerular microvascular endothelial cells may result in protein leakage to urine (proteinuria) or intravascular thrombosis (thrombotic microangiopathies), which often proceed to severe renal disease or kidney failure (Patrakka and Tryggvason 2010) . Human glomerular endothelial cells are of particular interest to explore the involvement of Shiga toxins (Stxs) in the frightening outcome of infections caused by enterohemorrhagic Escherichia coli (EHEC) bacteria. EHEC are the human-pathogenic subgroup of Stxproducing E. coli (STEC) that provokes life-threatening hemorrhagic colitis and hemolytic uremic syndrome (HUS) in humans (Spinale et al. 2013; Karpman and Ståhl 2014; Lee et al. 2016) . The most effective and so far best characterized virulence factors of humanpathogenic EHEC strains are Stxs of subtype 1a and 2a (for nomenclature of Stxs refer to Scheutz et al. 2012) . Stxs are delivered into the colon and then transferred into the circulation, where granulocytes are discussed as potential Stx transporters (Te Loo et al. 2000; Brigotti 2012; Brigotti et al. 2013; Carnicelli et al. 2016 ). Stxmediated injury of glomerular endothelial cells is, to the best of current knowledge, the key event that results in acute renal impairment underlying the pathogenesis of HUS (Richardson et al. 1988; Obrig and Karpman 2012) .
Stx1a and Stx2a, the clinically important Stx subtypes (Melton-Celsa 2014), belong to the group of AB 5 toxins (Beddoe et al. 2010 ) and exhibit preferential binding to the glycosphingolipid (GSL) globotriaosylceramide (Gb3Cer, Galα4Galβ4Glcβ1Cer) and somewhat lower affinity to globotetraosylceramide (Gb4Cer, GalNAcβ3Galα4Galβ4Glcβ1Cer), holding particularly true for Stx1a when compared to Stx2a ). Both, Gb3Cer and Gb4Cer, represent the dominant neutral GSLs of human endothelial cells derived from various vascular beds (Müthing et al. 2009; Bauwens et al. 2013 and references therein). The distribution of the toxin's receptor GSLs in membrane microdomains, also referred to as lipid rafts (Pike 2009 ), seems to play a functional role in efficient binding of Stx, subsequent internalization and intracellular routing of the toxin-receptor complex as well as retrotranslocation of the toxin across the membrane of the endoplasmic reticulum to the cytosol (Takenouchi et al. 2004; Lencer and Saslowsky 2005; Smith et al. 2006; Hanashima et al. 2008; Ewers and Helenius 2011) . Detergent-resistant membranes (DRMs) are commonly used as lipid raft-analogous supramolecular assemblies aimed at unraveling, for example, the recruitment of membrane proteins or lipids to the insoluble or soluble part of the plasma membrane (Brown 2006; Lingwood and Simons 2007) . This concept is widely employed in assessing lipid raft association of a given protein or lipid, although their use has met some criticism (Klötzsch and Schütz 2013) .
GSLs are members of the membrane-bound glycocalyx and belong to the structurally very diverse group of sphingolipids (Miller-Podraza 2000; Levery 2005; Farwanah and Kolter 2012) . GSLs have been implicated to play a role in a variety of diseases such as cancer due to aberrant glycosylation or as attachment sites for infectious pathogens (Kolter 2011; Holst et al. 2013) . The biosynthesis of GSLs of the common GSL families (globo-, lacto-, neolacto-and ganglio-series) starts with the enzyme glucosylceramide (GlcCer) synthase (UDP-glucose: ceramide glucosyltransferase, EC 2.4.1.80), catalysing the initial step of the GlcCer-based GSL biosynthesis (Kolter and Sandhoff 2006; Wennekes et al. 2009; Merrill 2011; Kolter 2012; Jennemann and Gröne 2013) . Lactosylceramide (Lc2Cer), produced by transfer of galactose to GlcCer, is the linchpin for the ensuing differentiation into the different GSL families. In case of globo-series GSLs, Lc2Cer is stepwise elongated to Gb3Cer and Gb4Cer, the eponymous core-structures of globo-series GSLs (Kolter and Sandhoff 2006; Wennekes et al. 2009; Merrill 2011; Kolter 2012; Jennemann and Gröne 2013) . Inhibitors of GlcCer synthase have found wide application aimed at unraveling the biological functions of GSLs and the ceramide analog D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) is a frequently used inhibitor of GSL biosynthesis (Koma et al. 2000; Rajesh et al. 2005; Pescio et al. 2012; Chatterjee et al. 2013; Mishra et al. 2015) for studying the involvement of GSLs in fundamental biological processes such as cellular signaling and cell growth or angiogenesis and cell differentiation (Yanagisawa and Yu 2007; Heiskanen et al. 2009 ) as well as bacterium-host protein-carbohydrate interactions (Ilver et al. 2003; Miller-Podraza et al. 2005 , 2009 ).
Stx GSL receptors and their lipid environment in cellular membranes have been recently scrutinized by us for primary human brain microvascular endothelial cells (pHBMECs) (Legros et al. 2017) . So far, the presence of Gb3Cer has been reported for primary cultures of human glomerular endothelial cells (van Setten et al. 1997; Te Loo et al. 2000; Pijpers et al. 2001; Warnier et al. 2006; Amaral et al. 2013; Girard et al. 2015) . However, a detailed study on Stx GSL receptors and the principal lipid composition of membrane microdomains of primary human renal glomerular endothelial cells (pHRGECs), which represent a key cell type of the kidney in course of developing life-threatening HUS as the worst sort of Stxmediated extraintestinal complications in EHEC infections, remains to be done. Here we provide novel data on the fine structures of globo-series receptor GSLs for Stx1a and Stx2a subtypes, the lipid assembly of microdomains employing lipid raft-analog DRM and nonDRM fractions regarding their content of Gb3Cer and Gb4Cer, glycerophospholipids and the canonical lipid raft-markers cholesterol and sphingomyelin (SM). Moreover, we report on the effects of the GSL biosynthesis inhibitor D-PDMP on lipid composition of the membrane liquid-ordered and liquid-disordered phase of pHRGECs. Proceedings in understanding the interaction of Stxs with the cell membrane of pHRGECs on molecular level will help to unravel the functional role of GSL association with lipid rafts in human endothelial cells of the kidney regarding binding and internalization of Stxs as the major cause of EHEC infections with a fatal outcome.
Results
Under consideration of the fact that pHRGECs represent fastidious and sensible primary cells, we used pHRGECs in very early passages until passage 7 for cell production. By doing so, we avoided employment of cells in the beginning of exhibiting signs of senescence and/ or dedifferentiation, which might occur from passage 10 on. Microscopic views of pHRGECs passaged for a period of several weeks are shown in the Supplementary data, Figure S1 demonstrating the cell shapes at increasing time points of continuous cultivation. Stages of cell propagation are exemplarily shown for passage 1 (P1), passage 7 (P7), passage 12 (P12) and passage 18 (P18). pHRGECs of passage 7 were used for Stx-receptor analysis under standard cultivation and the different physiological conditions described in the following paragraphs.
Identification of Stx receptors Gb3Cer and Gb4Cer using TLC overlay detection
In order to identify neutral GSLs of the globo-series as potential Stx receptors, we performed at first thin-layer chromatography (TLC) separation of the neutral GSL fraction from pHRGECs and stained the separated GSLs with orcinol as shown in Figure 1A . The orcinol stain suggests, when compared to reference neutral GSLs from human erythrocytes (R1), the presence of Gb3Cer and Gb4Cer, which was confirmed by TLC immunostaining using anti-Gb3Cer ( Figure 1B ) and anti-Gb4Cer antibody ( Figure 1C ). The immunopositive double band of each GSL provides evidence for the occurrence of various lipoforms, presumably based on fatty acid heterogeneity of the ceramide moiety (later on determined by mass spectrometry as outlined in the following paragraph). The ensuing overlay assay with Stx1a and Stx2a, the most relevant Stx subtypes released by human-pathogenic EHEC bacteria, revealed double bands at the sites of Gb3Cer in the chromatograms for Stx1a ( Figure 1D ) and Stx2a ( Figure 1E ) in comparison to the corresponding anti-Gb3Cer immunostain (see Figure 1B ). However, using purified Stx subtypes, the less effective Stx-receptor Gb4Cer was only detected in the Gb4Cer-overloaded reference mixture (R1) of human erythrocytes and not in the neutral GSL preparation of pHRGECs, neither by Stx1a ( Figure 1D ) nor by Stx2a ( Figure 1E ).
Gb3Cer and Gb4Cer lipoforms determined by mass spectrometry
Based on the electrospray ionization (ESI) positive ion mass spectrometry (MS) MS 1 spectrum obtained from immunodetected Gb3Cer double bands of the neutral GSL fraction of pHRGECs ( Figure 2A ), GSL structures of Gb3Cer (d18:1, C16:0), Gb3Cer Figure 2B and explained by the corresponding fragmentation scheme in Figure 2C . The fragment ions were assigned according to the nomenclature of Costello 1988a, 1988b together with 20 μg of reference neutral GSLs from human erythrocytes (R1) and stained with orcinol (A). Stx receptors Gb3Cer and Gb4Cer were detected by TLC immunostaining with anti-Gb3Cer (B) and anti-Gb4Cer antibody (C). Binding of Stxs towards GSLs was determined in TLC overlay assays using Stx1a (D) and Stx2a (E) with the corresponding anti-Stx1 and anti-Stx2 antibody, respectively. Applied amounts of neutral GSLs of pHRGECs were equivalent to 2 × 10 5 cells for the anti-Gb3Cer immunostain (B), the anti-Gb4Cer immunostain (C), and the Stx1a (D) and the Stx2a (E) overlay assay, respectively. Amounts of reference neutral GSLs are 2 μg in the anti-Gb3Cer immunostain (B), 0.2 μg in the anti-Gb4Cer immunostain (C), and 2 μg in the Stx1a (D) and Stx2a overlay assay (E), respectively. Table I .
C23:0) variant at m/z 1347.98 carrying an odd-numbered fatty acid residue. An example for verification of proposed structures is the MS 2 spectrum of Gb4Cer (d18:1, C24:0) in Figure 3B together with the corresponding explanatory fragmentation scheme ( Figure 3C ).
Distribution of Gb3Cer and Gb4Cer to DRM and nonDRM fractions
Proof of F1-F8 fractions obtained from sucrose gradient ultracentrifugation was performed by exploring the occurrence of flotillin-2, a microdomain scaffolding and lipid raft-associated protein of mammalian cells (Head et al. 2014) , in DRM and nonDRM fractions. The Western blot detection of flotillin-2 indicated preferential distribution of this lipid raft marker in canonical DRM fraction F2 ( Figure 4A ) and only minute quantities in the nonDRM bottom fractions F7 and F8. A further Western blot, performed with sucrose gradient fractions achieved from a second independent biological replicate of pHRGECs, confirmed the association of flotillin-2 with lipid rafts (Supplementary data, Figure S2A ). Somewhat enriched relative content in DRM fractions F1-F3 was observed for Gb3Cer amounting to 53%, accompanied by 18% in the intermediate fractions F4-F6 and 29% in the bottom fractions F7 and F8 of the nonDRM fractions ( Figure 4B ) as determined by TLC overlay scanning. A further anti-Gb3Cer TLC overlay assay of sucrose gradient fractions, derived from a second independent biological replicate of pHRGECs, corroborated this distribution pattern as shown in the Supplementary data, Figure S2B . Thus, moderately pronounced distribution to DRM fractions (F1-F3) with approximately 50% as average for Gb3Cer in the two independent investigations indicate some enrichment of the high-affinity Stx-receptor Gb3Cer in the liquid-ordered membrane phase. Therefore, both biological replicates of pHRGECs substantiate association of Gb3Cer with lipid rafts and its occurrence in a microdomain environment.
An inferior occurrence in DRMs was observed for Gb4Cer ( Figure 4C ), exhibiting a similar distribution (except F1) to the individual gradient fractions. Gb4Cer of replicate 1 distributes with 33% to DRM fractions F1-F3, 42% to intermediate fractions F4-F6 and 25% to bottom fractions F6-F7, indicating presence of 67% of Gb4Cer in nonDRM fractions. TLC overlay assays analysis of an additional independent second biological replicate of pHRGECs gave a more pronounced partition of Gb4Cer to the DRM fractions as demonstrated in the Supplementary data, Figure S2C . Thus, roughly averaged 42% content of Gb4Cer in DRM fractions + ions are compiled in Table I . The preparation of neutral GSLs was separated by TLC, followed by immunostaining of Stx receptors with anti-Gb3Cer and anti-Gb4Cer antibodies ( Figure 1B and C, respectively). GSLs of positive bands were obtained by preparative TLC and their structures were determined by ESI mass spectrometry in positive ion mode. The MS 1 spectrum of Gb3Cer species is displayed in Figure 2A , together with the CID proof of the proposed Gb3Cer (d18:1, C24:1) ( Figure 2B ) and auxiliary fragmentation scheme ( Figure 2C ). The MS 1 spectrum of Gb4Cer species is given in Figure 3A , together with an example of CID verification of proposed Gb4Cer (d18:1, C24:0) structure ( Figure 3B ) and the corresponding fragmentation scheme ( Figure 3C ).
obtained from two independent approaches hint to a slightly enhanced content of the low-affinity Stx-receptor Gb4Cer in the liquid-ordered membrane phase. The less sensitive Stx1a and Stx2a (than the used polyclonal antibodies regarding detection of GSL receptors) gave a somewhat different TLC overlay picture of DRM and nonDRM distribution of Gb3Cer as shown for Stx1a in Figure 4D and for Stx2a in Figure 4E . Stx1a-binding Gb3Cer accumulated with 66% in the two DRM fractions F2 and F3, while adjacent intermediate fractions F4-F6 revealed a relative content of 21% and those of the bottom fractions F7 and F8 only 13% ( Figure 4D ). Gb4Cer was undetectable in this Stx1a-binding assay using a GSL preparation corresponding to 8 × 10 5 pHRGECs. An even more pronounced relative content of Gb3Cer was determined in the Stx2a TLC overlay assay of DRM fractions F2 and F3, amounting to 76%, accompanied by 17% in the intermediate fractions F4-F6, followed by 7% in the bottom fractions F7 and F8 ( Figure 4E ). Gb4Cer was only faintly detected in DRM fraction F2, giving a weak hint of slightly preferred occurrence in microdomains, but excluding a reliable relative quantification in DRM and nonDRM fractions. Thus, the Stx1a and Stx2a TLC binding assays revealed a somewhat more pronounced DRM association in comparison to the anti-Gb3Cer TLC overlay detection.
D-PDMP treatment of pHRGECs
In order to explore putative cytotoxic effects of the ceramide analogon D-PDMP, pHRGECs at 50% confluence were exposed to increasing concentrations of D-PDMP. Cells propagated in the presence of 1 to 10 μM D-PDMP did not exhibit any signs of phenotypic changes or reduction in doubling times during cultivation for 12, 24, 36 or 72 h. According to results from these pre-experiments, pHRGECs were treated with 5 μM D-PDMP for 72 h after reaching full confluence and then analyzed regarding GSL, cholesterol and phospholipid content in DRM and nonDRM fractions as outlined in the following paragraphs (see below).
D-PDMP treatment reduced total Gb3Cer content and strengthened Gb3Cer prevalence in DRM fractions Figure 5A . The same counts for biological replicate 2, which exhibited a very similar distribution pattern (Supplementary data, Figure S3A ) as illustrated by the values of scanned immunopositive bands in the bar graph of Figure 5A for replicate 1 (black bars) and replicate 2 (gray bars). The summed averaged values of both replicates roughly amount to 65% relative content in DRMs giving repeatedly evidence for association of Gb3Cer with lipid raft microdomains.
After exposing pHRGECs to D-PDMP, substantial reduction of total Gb3Cer was observed as shown for replicate 1 in the lower panel of Figure 5B and for replicate 2 in the Supplementary data, Figure S3B , determined by densitometric quantification of TLC band intensities related to reference R1 positive controls. D-PDMP treatment resulted in a decline of total Gb3Cer down to roughly 45% determined as average for both replicates in relation to Gb3Cer values of untreated control cell cultures (set to 100%).
On the other hand, the preferred relative distribution of Gb3Cer to DRM fractions was considerably strengthened upon D-PDMPtreatment as deduced from the TLC overlay assays of replicate 1 ( Figure 5B , lower panel) and replicate 2 (Supplementary data, Figure S3B ) and demonstrated by the bar charts of both replicates portrayed in Figure 5B . D-PDMP-treated pHRGECs of replicate 1 exhibited a reinforced occurrence of Gb3Cer in the DRM fractions, accompanied by corresponding lower relative content of Gb3Cer in the nonDRM fractions shown in the lower panel of Figure 5B and portrayed in the bar chart of Figure 5B (black bars). This shift to enhancement in DRM fractions was also observed for replicate 2 as demonstrated in the Supplementary data, Figure S3B and the bar diagram of Figure 5B (gray bars). In terms of numbers, the average sum of the relative amounts of Gb3Cer in DRM fractions (F1-F3) of both replicates increased from 65% to 84%, indicating a shift to 
D-PDMP treatment reduced total Gb4Cer content and strengthened Gb4Cer prevalence in DRM fractions
The pHRGEC control cell cultures without D-PDMP exhibited an almost equalized distribution of Gb4Cer in the DRM fractions (with the exception of F1) and nonDRM fractions with only slight augmentation of Gb4Cer in DRM fraction F2 as shown for replicate 1 in the lower panel of Figure 6A . This holds also true for replicate 2 as demonstrated in Supplementary data, Figure S3C and is illustrated in the bar chart of the upper panel of Figure 6A for replicate 1 (black bars) and replicate 2 (gray bars) amounting to a rough summed average of 43% Gb4Cer content in DRMs of the two replicates. D-PDMP treatment caused substantial diminishment of Gb4Cer as shown for replicate 1 in the lower panel of Figure 6B and for replicate 2 in the Supplementary data, Figure S3D , determined by densitometric quantification of TLC band intensities related to reference R1 positive controls. More precisely, exposure of pHRGECs to D-PDMP resulted in a decline of total Gb4Cer down to approximately 24% determined as average for both replicates in relation to Gb4Cer values of untreated control cell cultures (set to 100%). On the other side, the slightly higher relative content of Gb4Cer in DRM fractions was vastly reinforced upon D-PDMP-treatment as deduced from the TLC overlay assays of replicate 1 ( Figure 6B , lower panel) and replicate 2 (Supplementary data, Figure S3D ) and illustrated by the bar charts of both replicates given in Figure 6B . The TLC overlay assay of replicate 1 in the lower panel of Figure 6B indicates a shift towards heightened partition of Gb4Cer to the DRM fractions and concomitant lowering of Gb4Cer content in the nonDRM fractions portrayed in the bar chart of Figure 6B (black bars). This effect of D-PDMP was also noticed for replicate 2 as demonstrated in the Supplementary data, Figure S3D and the bar diagram of Figure 6B (gray bars).
In terms of numbers, D-PDMP caused a shift from relative average content of 43% Gb4Cer in DRM fractions (F1-F3) of both replicates to an increased content of 68% indicating reinforced association of Gb4Cer with membrane microdomains upon D-PDMP treatment.
D-PDMP-caused relative increase of cholesterol content in DRM fractions
Cholesterol distributes with sizeable prevalence to DRM fractions (F1-F3, total 2.27 μg/10 6 cells or 58%) of pHRGECs when grown without D-PDMP (− D-PDMP) as shown for biological replicate 1 in Figure 7A (black bars). Minor quantities were detectable in the intermediate fractions (F4-F6, total 0.18 μg/10 6 cells or 4%), whereas considerable amounts of cholesterol were present in the bottom fractions (F7 and F8, total 1.51 μg/10 6 cells or 38%) as visible in the bar diagram of Figure 7A (black bars). The manganese(II) chloride-stained TLC-separated cholesterol bands of the sucrose gradient fractions derived from biological replicate 1 are shown as an example beneath the bar chart. This pattern closely resembles the one obtained from gradient fractions of biological replicate 2 as can be inferred from the bar chart in Figure 7A (gray bars). Added averaged values of the two replicates roughly account for 52% content in DRMs indicating association of cholesterol with the membrane liquid-ordered phase. After exposure of pHRGECs to D-PDMP, a substantial relative cholesterol increase was detectable in the DRM fractions F1-F3 (total 2.65 μg/10 6 cells or 69%) together with a concomitant relative decrease of cholesterol in the nonDRM bottom fractions F7 and F8 as demonstrated in Figure 7B (black bars) and exemplarily shown for stained TLC-separated cholesterol bands of gradient fractions from replicate 1 below the bar diagram. A similar distribution pattern along with lower relative content of cholesterol in the bottom fractions F7 and F8 was recognizable for replicate 2 as can be deduced from the bar graph of Figure 7B (gray bars). Summed relative quantities of cholesterol in DRM fractions (F1-F3) approximate to 66%, indicating its distinct increase in the liquidordered membrane phase, giving a hint to slight postponement of some cholesterol to membrane microdomains of pHRGECs upon D-PDMP-treatment.
Phospholipids in DRM and nonDRM fractions of pHRGECs in the absence of D-PDMP
Analysis of TLC-separated phospholipids of untreated cells revealed a balanced distribution of the major glycerophospholipid PC to DRM fractions F1-F3 (42%) and nonDRM bottom fraction F7 and F8 (47%), accompanied by inferior quantities of PC in the nonDRM intermediate fractions F4-F6 (11%) as shown for biological replicate 1 in Figure 8A . The sphingophospholipid sphingomyelin (SM) was identified as an unambiguous lipid raft marker for pHRGECs due to its restricted appearance in DRM fractions F1-F3 with eye-catching prevalence in canonical DRM fraction F2, labeled with an arrowhead in the TLC lane of fraction F2 in Figure 8A . SM was undetectable in nonDRM fractions (including intermediate fractions F4-F6 and bottom fractions F7 and F8), whereas lysophosphatidylcholine (lyso-PC) plays the pendant role of a biomarker for the liquid-disordered membrane phase in the bottom fractions F7 and F8. Lyso-PC occurs exclusively in these fractions, which exhibit separation of lyso-PC on a TLC position below SM (and self-evidently vastly below PC) as marked with an arrowhead in the TLC lane of fraction F7 in Figure 8A . As a second example, the uniqueness of SM distribution to DRM fractions with prevalence in DRM fraction F2 and of lyso-PC in nonDRM bottom fractions F7
and F8 is shown for replicate 2 in the Supplementary data, Figure S4A . Figure 8B .
The absence of any SM species is discernable in the overview mass spectrum of the lipid extract prepared from nonDRM bottom fraction F7 as shown in Figure 8C . The second most prominent difference in comparison to fraction F2 was the exclusive presence of lyso-PC (16:0) and lyso-PC (18:1) in fraction F7, detectable by [M+H] + ions with m/z values at 496.33 and 522.34, respectively, and emphasized by grayed boxes in the spectrum. Thus, both lyso-PC species can be considered as reliable markers of the nonDRM bottom fractions and thus of the liquid-disordered membrane phase of pHRGECs. In addition, significant differences regarding PC distribution were identified by complete absence of PC (32:0) and exceptional presence of doubly unsaturated PC (34:2) at m/z 758.58 and PC (36:2) at m/z 786.60 in this typical nonDRM bottom fraction representing the liquid-disordered membrane phase.
Phospholipids in DRM and nonDRM fractions of pHRGECs after D-PDMP treatment
The exposure of pHRGECs to D-PDMP (+ D-PDMP) resulted in partition of 52% of PC in DRMs (F1-F3), 38% in nonDRM bottom fractions (F7 and F8) and residual 10% in the nonDRM intermediate fractions (F4-F6) as shown for replicate 1 in Figure 9A . The sphingophospholipid SM and lyso-PC distributed strictly to DRM fractions (predominantly F2 of fractions F1-F3) and nonDRM bottom fractions (F7 and F8), respectively, as determined before in case of untreated pHRGECs. Thus, D-PDMP did not alter the distribution of SM as a biomarker for the liquid-ordered (lipid raft or microdomain) membrane phase and of lyso-PC as a characteristic compound of the liquid-disordered membrane phase. Analysis of replicate 2 confirmed the unique distribution of SM to DRM fractions and of lyso-PC to nonDRM fractions while retaining prevalence of SM in DRM fraction F2 and of lyso-PC in nonDRM bottom fractions F7 and F8 upon D-PDMP treatment as shown in the Supplementary data, Figure S4B . 837.67, respectively ( Figure 9B ). Identified SM species are highlighted by grayed boxes in the spectrum and were further verified by CID experiments (data not shown). The exclusive presence of SM discriminates DRM fraction F2 from nonDRM bottom fraction F7, which lacks this lipid raft marker (see below). Other apparent ions could be assigned to PC (30:0), PC (32:1/32:0), PC (34:1) and PC (36:2/36:1) based on m/z values of protonated and sodiated ion species as indicated in the overview mass spectrum in Figure 9B . SM species were undetectable in the MS 1 spectrum obtained from the lipid extract of nonDRM bottom fraction F7 as shown in Figure 9C . On the other hand, lyso-PC (16:0) and lyso-PC 
Synopsis of PC, SM and lyso-PC distribution
A summary of the phospholipid distribution of PC, SM and lyso-PC of the two replicates in the absence and presence of D-PDMP, based on TLC scanning as shown for replicate 1 in Figure 9A , is given in Figure 10 . Lyso-PC, identified as marker of the liquid-disordered membrane phase and occurring only in nonDRM fractions F7 and F8, resides with average 42% relative content of the two replicates in F7 and with 58% in F8 of untreated cells Figure 10C (left panel). The exclusive distribution of lyso-PC to the two bottom fractions was retained upon D-PDMP treatment with average relative content amounting to 55% in F7 and 45% in F8 without occurrence in others than these two bottom fractions Figure 10C (right panel). Thus, D-PDMP did not change the presence of lyso-PC in the liquid-disordered membrane phase of pHRGECs keeping this specific distribution of lyso-PC unaltered.
Discussion
Stx receptors of primary human endothelial cells have been so far mostly imprecisely analyzed. This concerns their exact structure, providing only preliminary data on the oligosaccharide moiety and/ or speculative information on the lipid anchor, ignoring the ceramide moiety and leaving its structure unexplored. In particular the latter is known (at least from TLC analysis) to exhibit considerable heterogeneity due to variable chain length or degree of unsaturation of the sphingoid base and the N-linked fatty acid (Levery 2005; Müthing and Distler 2010; Merrill 2011; Farwanah and Kolter 2012) . Structural analysis of Stx-receptor GSLs including mass spectrometry has been performed in the past for primary endothelial cells in case of human umbilical vein endothelial cells (Müthing et al. 1999) . At that time fast atom bombardment mass spectrometry was used by us combined with immunochemical detection. More recently, state of the art MS technologies such as nanoESI mass spectrometry have been employed for primary human brain microvascular endothelial cells (pHBMECs) (Legros et al. 2017 (Amaral et al. 2013) or proving the Stx2-caused cellular damage upon exposing the cells to a GlcCer synthase inhibitor (Girard et al. 2015) . This lack of data prompted us to explore the structural features of Stx-receptor GSLs from pHRGECs. We now close this gap of knowledge with a comprehensive structural characterization of Gb3Cer and Gb4Cer of pHRGECs. Gb3Cer and Gb4Cer variants with Cer (d18:1, C16:0), Cer (d18:1, C22:0) and Cer (d18:1, C24:1/ C24:0) are the prevailing lipoforms found in pHRGECs in this study. These structures are not unique for pHRGECs, but have been determined in other types of primary human endothelial cells. Human umbilical vein endothelial cells (Müthing et al. 1999; Okuda et al. 2010 ) and pHBMECs (Legros et al. 2017 ) as well as immortalized human endothelial cells derived from various vascular beds (Schweppe et al. 2008; Müthing et al. 2009; Betz et al. 2011 Betz et al. , 2012 Bauwens et al. 2013 ) share the mentioned Stx-receptor GSLs of the globo-series. The ceramide fatty acid heterogeneity of these main neutral GSLs of human endothelial cells arises from saturated C16:0, C22:0 and C24:0 fatty acids on the one hand and monounsaturated C24:1 fatty acid on the other hand. Because these variants have so far been detected in all human micro-and macrovascular endothelial cells analyzed by us, they suggest a certain functional impact for endothelial cells of yet unknown biological or physiological processes. Previous reports provided indications that binding of verotoxin 1 (synonymous with Stx1a) and verotoxin 2c (synonymous with Stx2c) towards GSLs in a lipid matrix is modified by the acyl chain length and degree of unsaturation of the fatty acid giving rise of different Gb3Cer lipoforms (Kiarash et al. 1994 ). In addition, Gb3Cer tail saturation has been recently shown to exhibit drastic effects on lipid bilayer properties and phase behavior (Pezeshkian et al. 2015) . Furthermore, ceramide fatty acid hydroxylation seems to influence the binding of verotoxin 1 (synonymous with Stx1a) and verotoxin 2 (synonymous with Stx2a) towards Gb3Cer variants (Binnington et al. 2002) . This type of ceramide modification may impact membrane organization (Schütte et al. 2015 ) and has been recently described by us as a feature of Gb3Cer in primary porcine brain capillary endothelial cells being highly sensitive towards the cytotoxic action of Stx2e ). Interestingly, the ganglioside GM1 lipoform harboring unsaturated acyl chains was the only GM1 variant enabling efficient sorting of cholera toxin (with similar AB 5 structure like Stx) from the plasma membrane to the trans-Golgi network and the endoplasmic reticulum, suggesting a lipid sorting by ceramide structure . Moreover, only GM1 species containing cis-unsaturated or short acyl chains in the ceramide moiety were capable of transcytosis from apical to basolateral membranes thereby bypassing the retrograde pathway (Saslowsky et al. 2013) . It is therefore tempting to speculate that various Gb3Cer lipoforms, such as Gb3Cer (d18:1, C16:0) with saturated short fatty acid acyl chain or Gb3Cer (d18:1, C24:1) with monounsaturated long-chain fatty acid, may fulfill important but yet unknown tasks as unwitting participants on subcellular retrograde trafficking of Stx. Importantly, both Gb3Cer lipoforms with C16:0 and C24:1 fatty acid have been identified as prevalent Gb3Cer variants in all primary and immortalized human endothelial cells analyzed previously in detail by us (Müthing et al. 1999; Schweppe et al. 2008; Müthing et al. 2009; Betz et al. 2011 Betz et al. , 2012 Bauwens et al. 2013; Legros et al. 2017 ) and described in this paper for pHRGECs. However, besides intrinsic GSL structural features, the lipid and protein environment of Stx GSL receptors in microdomains may certainly influence their accessibility towards their binding proteins and therefore affect the biological activity of the various Stx subtypes Mahfoud et al. 2010; Lingwood 2011) . The organization of the plasma membrane in microdomains, also known and coined by some authors as lipid rafts (Ishitsuka et al. 2005; Rao and Mayor 2005; Pike 2009; Sonnino et al. 2014) , seems to be a functional requirement for binding and efficient internalization of toxins released by pathogens. This has been described for vacuolating toxin of Helicobacter pylori, perfringolysin O and beta-toxin of Clostridium perfringens or listeriolysin O of Listeria monocytogenes (Schraw et al. 2002; Gekara and Weiss 2004; Ohno-Iwashita et al. 2010; Nagahama et al. 2015) . Lipid rafts are located in the outer leaflet of the two-layered plasma membrane and represent supramolecular assemblies enriched in cholesterol and (glyco)sphingolipids (Lingwood and Simons 2010; Sonnino and Prinetti 2013) . GSLs participate as driving forces in the formation of membrane microdomains (Sonnino et al. 2006 ) acting as explicit attachment platforms for GSL-binding toxins. This holds true for cholera toxin of Vibrio cholerae, alpha-toxin of Clostridium perfringens, and Stxs from pathogenic E. coli, which are subsequently internalized and transported retrogradely to intracellular targets (Lencer and Saslowsky 2005; Chinnapen et al. 2007; Wernick et al. 2010; Ewers and Helenius 2011; Cho et al. 2012; Sandvig et al. 2014; Aigal et al. 2015; Oda et al. 2015) . Enhanced content of cholesterol and sphingolipids in the liquid-ordered phase renders lipid rafts relatively robust against solubilization by nonionic detergents, allowing isolation of DRMs and accompanying nonDRM fractions by sucrose density gradient ultracentrifugation (Brown and Rose 1992; London and Brown 2000) . DRMs ideally float at the interface between 5% and 30% sucrose, whereas solubilized lipids reside in the nonDRM fractions below DRMs in the discontinuous gradient. Although DRMs are not the same as pre-existing lipid rafts and cannot be directly equated with lipid rafts (Brown 2006; Lingwood and Simons 2007) , the analysis of DRM and nonDRM preparations is a commonly used procedure for assigning lipid and protein raft affinity (Ehehalt et al. 2008; Gonnord et al. 2009; Podyma-Inoue et al. 2012; Manni et al. 2015) . This includes Stx-binding studies (Katagiri et al. 1999; Smith et al. 2006; Mahfoud et al. 2009 ), whereby DRMs are supposed at least to resemble these microdomain assemblies in cellular membranes (Morris et al. 2011; Ciana et al. 2014) . The weakness of the DRM approach lies in some principal limitations to this in vitro method (Klötzsch and Schütz 2013) . For instance, GSLs can reorganize into different membranes when exposed to detergents, a fact that has been described for gangliosides in murine brain tissue sections under conditions of lipid raft isolation (Heffer-Lauc et al. 2007) . At +4°C Triton X-100, the detergent being frequently used by us and others, was found to cause significant redistribution of the disialoganglioside GD1a from gray matter into the white matter giving evidence that a ganglioside can "jump" between different membranes of different cell types or tissues upon treatment with detergent, a process which might also occur in cell cultures. The shift to low temperature has most likely an effect on the phase state of the membrane and may alter its physical properties, a further disadvantage of using DRMs (Li et al. 2000; London and Brown 2000; Klötzsch and Schütz 2013) . While usually low concentrations of detergent in the order of 1% are used for DRM isolation, one should bear in mind that high concentrations of detergent have been reported to change the thermodynamic properties of a lipid mixture and most likely affect the observed lipid domains (Heerklotz 2002) . Thus, the question remains on whether these DRMs correspond to really existing membrane domains (Sezgin et al. 2017 ) and the observed discrepancies remain an open problem, one that may bear consequences on the interpretation of many published data (Manni et al. 2015) . However, using the DRM approach, we found some hints for lipid raft association of Gb3Cer, the major Stx receptor, in pHRGECs. Evidence is based on prevalence of Gb3Cer in DRMs and colocalization with the canonical lipid raft markers SM and cholesterol as well as flotillin-2 in the liquid-ordered membrane phase. The same subcellular distribution and lipid environment for Gb3Cer have been recently described for pHBMECs (with emphasis on the "p" for primary cells) by us (Legros et al. 2017) , indicating that human primary microvascular endothelial cells of the brain and the kidney exhibit identical lipid raft markers. Furthermore, very similar DRM and nonDRM distribution, with evidence for somewhat lowered lipid raft association, holds true for Gb4Cer of pHBMECs (Legros et al. 2017 ) and for pHRGECs as explored in this study. The comparison of pHBMECs and pHRGECs with immortalized HBMECs (Betz et al. 2011 ) and immortalized HRGECs (Betz et al. 2012 ) revealed on the one hand the same set of Stx-receptor GSLs (as mentioned above). On the other hand it showed inverse distribution of Gb3Cer and Gb4Cer to DRM and nonDRM fractions with preference of both GSLs in the bottom fractions in case of immortalized HRGECs (Betz et al. 2012 ). This uncommon membrane distribution remains still an open question leaving the reason for this discrepancy, most likely due to immortalization, an obscure matter.
Using receptor-binding StxB (single B-subunit of Stx), Warnier and co-authors could show in a previous study for primary human glomerular microvascular endothelial cells that Stx receptors distributed primarily in DRM fraction F2 of a sucrose gradient built up out of 7 fractions (Warnier et al. 2006) . Their results are in overall agreement with our findings for pHRGECs exhibiting preferential occurrence of Stx-receptor GSLs in and Stx-binding to GSLs of the DRM fractions. Notably in the context of microdomain association of Stx receptors and the pathology of HUS was the discovery of Khan and colleagues that binding of verotoxin 1 (synonymous with Stx1a) and of verotoxin 2 (synonymous with Stx2a) to tissue sections of human adult renal glomeruli was found detergent resistant (Khan et al. 2009 ). On the other hand, verotoxin binding to renal tubules was detergent sensitive suggesting that differential membrane Gb3Cer organization in glomeruli and tubules may provide a basis for the glomerular-restricted pathology of HUS. Lipid raft association of Gb3Cer was furthermore indirectly confirmed by cholesterol extraction resulting in strong verotoxin binding in poorly reactive adult glomeruli. This finding suggests that cholesterol can mask Gb3Cer in glomerular lipid rafts (Khan et al. 2009 ). Thus, Gb3Cer embedment into lipid rafts seems to be essential to the pathology of HUS and presence of Gb3Cer within such membrane microdomains in glomerular but not tubular cells may be the basis for the glomerular-restricted pathology of Stx-induced HUS (Ray 2009 ). Although not further specified, glomerular endothelial cells may be involved in the underlying events on cellular level (Khan et al. 2009 ). However, the relevance of membrane organization of GSLs in lipid rafts of pHRGECs and their functional impact in Stxmediated kidney damage through injuring endothelial cells of the blood-kidney barrier remain obscure and pose new questions on this matter.
Our investigation on the PL composition of DRM fractions F2 and nonDRM fractions F7, which largely represent the liquidordered and liquid-disordered phase of membranes, respectively, identified SM as a lipid raft marker and lyso-PC as a characteristic compound of the fluid membrane phase of pHRGECs. The results were similar to those previously obtained from DRM analyses of pHBMECs (Legros et al. 2017 ), Vero-B4 kidney epithelial cells (Steil et al. 2015) and lymphoid and myeloid cells . For the three different cell types we could show enrichment of GSLs in association with cholesterol and SM in DRMs as well as presence of lyso-PC in nonDRMs. More precisely, the detected SM variants with C16:0 and C24:0/C24:1 fatty acid in DRMs of pHRGECs coincided with prevalent Gb3Cer and Gb4Cer species harboring the same N-linked fatty acids. This homology between SM and GSL ceramides has been previously described for pHBMECs (Legros et al. 2017 ), a further indicator of similar lipid raft microdomains of both types of primary human endothelial cells. Moreover, when comparing F2 with F7 fractions mass spectrometrically, monotailed lyso-PC (18:1) and lyso-PC (16:0), which were detected as typical nonDRM marker in bottom fraction F7 of the sucrose gradients of pHRGECs in this study, are exactly the same previously found in the corresponding fractions prepared from pHBMECs (Legros et al. 2017 ), Vero-B4 cells (Steil et al. 2015) and lymphoid and myeloid cells ). Thus, lyso-PC (18:1) and lyso-PC (16:0) obviously represent common features of the liquid-disordered membrane phase of mammalian cells so far analyzed. The same holds true for doubly unsaturated PC (34:2) and PC (36:2), when comparatively analyzing F2 and F7 fractions, which were found to preferentially distribute to the F7 fractions (representing the fluid membrane phase), while preferred occurrence was observed for unsaturated PC (32:0) in the liquid-ordered membrane fraction F2. Notably, PC (32:1) and PC (34:1) exhibited no apparent bias for any of the two membrane phases exhibiting approximately equal distribution in fractions F2 and F7. This trend of certain distribution of different PC lipoforms, which seems to result from the differences of acyl chain length and extent of unsaturation, has been previously reported by us for pHBMECs (Legros et al. 2017 ), Vero-B4 cells (Steil et al. 2015) and lymphoid and myeloid cells .
D-PDMP represents a well known inhibitor of GSL biosynthesis and treatment of cultured cells with this ceramide analog gives rise of GSL depletion (Inokuchi and Radin 1987; Okada et al. 1988; Shukla and Radin 1991; Mutoh et al. 1998; Koma et al. 2000; Pescio et al. 2012 ) and provides novel options for various clinical applications (Rajesh et al. 2005; Kolmakova et al. 2009; Chatterjee et al. 2013; Mishra et al. 2015) . Early investigations on human kidney proximal tubular cells revealed lowering of synthesized GSLs upon D-PDMP treatment in a concentration-dependent manner (Chatterjee et al. 1996) . In particular, this study of Chatterjee and co-workers has evidenced reduced cellular level not only of GlcCer and Lc2Cer, but also of Gb3Cer and Gb4Cer after exposing the cells to increasing concentrations of D-PDMP in the range between 2.5 and 20 μM. We could show for pHRGECs a D-PDMP-mediated decrease of Gb3Cer and Gb4Cer down to about half and quarter of its primordial content, respectively, using a working concentration of 5 μM of D-PDMP. This rather low concentration was chosen, because higher concentrations, e.g., usage of 40 μM D-PDMP, have been shown to cause phenotypic changes, reduction of cell growth rate and other harmful effects to in vitro propagated cells (Okada et al. 1988; Felding-Habermann et al. 1990 ). Apart from the decreasing effect of total GSLs, D-PDMP caused relative enrichment of Gb3Cer and Gb4Cer as well as of cholesterol in DRMs, whereas the proportional distribution of PC, SM and lyso-PC in the sucrose gradient fractions remained untouched by D-PDMP. In other words: exposure of pHRGECs towards D-PDMP reinforced lipid raft association of in quantity reduced remaining Stx receptors Gb3Cer and Gb4Cer. The condensation of GSLs and cholesterol in the liquidordered phase adds one further facet to the repertoire of effects of D-PDMP, which cannot be explained by the inhibition of GSL synthesis alone exceeding its activity beyond simple blocking of GSL biosynthesis. Further examples of as yet only partly explored effects over and above of D-PDMP-caused GSL depletion are the elimination of Src kinases from DRMs accompanied by affecting functional microdomain formation of lung cells (Inokuchi et al. 2000) , influencing of the expression state and function of glycosylphosphatidylinositol-anchored proteins in T lymphocytes (Nagafuku et al. 2003) , alteration of cellular cholesterol homeostasis of fibroblasts by modulating the endosome lipid domains (Makino et al. 2006 ) and restoring of insulin receptor from caveolae of TNFα-treated adipocytes (Sekimoto et al. 2012) . Furthermore, accumulation of ceramide was detected as a characteristic feature observed upon exposure of murine fibroblasts (Okada et al. 1988) and ConA-stimulated T lymphocytes (Felding-Habermann et al. 1990 ) to D-PDMP. Since D-PDMP treatment can result in out-sized ceramide concentration that appears independent of GlcCersynthase inhibition, such an increase in ceramide may contribute to reconfiguration of DRMs observed by us for pHRGECs. As a consequence, investigations on ceramide level should be considered in future investigations when analyzing D-PDMP-mediated effects in cell cultures. The described D-PDMP-caused effects are raising the question of whether additional physiological activities of D-PDMP beyond its primary action of Stx-receptor depletion could be beneficial for survival of target cells like glomerular endothelial cells of the human kidney. In this context it is noteworthy to mention that endothelial cells of the kidneys (pHRGECs) and the brain (pHBMECs) are not the only target cells in humans for Stxs released by EHEC bacteria. We have recently shown in an ex vivo cell culture model that human erythrocytes, which maturate in vivo in the bone marrow, represent at certain stages of development further moribund target cells for Stxs (Betz et al. 2016) . This discovery explains the dramatic decrease of erythrocytes and might be the reason for the huge demand of blood transfusion during onset of HUS. Hence, Stx-mediated damage of erythrocyte progenitor cells in the bone marrow may contribute to anemia observed in EHEC-caused extraintestinal complications. Novel MS-based imaging techniques aimed at the detection of lipids and particularly of GSLs in organ sections or membranes of cultured cells may be helpful in the future to scrutinize the histological background of Stx-mediated kidney pathology in a given tissue area (Murphy and Merrill 2011; Soltwisch et al. 2015) .
From our results it is tempting to speculate that lowered GSL biosynthesis by D-PDMP might result in reduced uptake of Stxs owing to reduced number of Stx receptors, which in turn might lead to enhanced refractiveness of pHRGECs towards the cytotoxic action of Stxs. Indeed, prevention of Stx2-caused damage of primary human glomerular endothelial cells and a human proximal tubular epithelial cell line has been demonstrated by using the GlcCer synthase inhibitor N-butyldeoxynojirimycin (synonymous to Miglustat) (Girard et al. 2015) . The application of this GlcCer synthase inhibitor evidenced that two different renal cell types, endothelial and epithelial kidney cells, were likewise protected from Stx2 cytotoxicity and morphology damage. Moreover, preincubation of cells with a compound named C-9-a competitive inhibitor of Gb3Cer synthesisprotected not only primary human glomerular endothelial cells from cytotoxic effects of Stx2 (Amaral et al. 2013 ), but also rats against the cytotoxic effects of Stx2 (Silberstein et al. 2011) . Thus, wishful thinking of lowering toxin-mediated cytotoxivcity of harmful toxins for humans has been verified in theses studies for Stx2 in cell cultures and in an animal model providing promising results for future clinical applications. Glycosylation inhibitors have been shown to be safe and efficient in patients with lipid storage diseases and might therefore be an approach based on GSL receptor depletion for specific antimicrobial therapy as proposed for pathogenic P-fimbriated E. coli bacteria (Svensson et al. 2006 ).
Conclusions
Collectively, improved knowledge on the complex assembly of endothelial plasma membranes, particularly of the lipid composition of their microdomains, and progress in understanding the preceding and still ongoing evolutionary adaptation of pathogens to their hosts with potential of overcoming mammalian species barriers are required for directed development of novel therapeutics against pathogens and released toxins. Oligosaccharide mimetics aimed at neutralization of sugar-binding toxins and inhibitors of GSL biosynthesis are challenging compounds to reduce binding of bacterial toxins to target cells and ensuing internalization by the cells aimed at winning the fight against infectious diseases (Sharon 2006; Svensson et al. 2006 ).
Materials and methods

Propagation of pHRGECs
Primary human renal glomerular endothelial cells (pHRGECs) were purchased from ScienCell TM (Carlsbad, CA; Cat. No. 4000 ). The lowercase "p" refers to "primary" in order to distinguish the cell type explored in this study from previous work and publications where we employed immortalized endothelial cells or endothelial cell lines (Betz et al. 2012; Bauwens et al. 2013) . Cryopreserved cells from the 1 st passage were thawed and cultured in a humidified atmosphere containing 5% CO 2 at 37°C in endothelial cell medium (ECM). Added supplements were 5% fetal bovine serum, 1% endothelial cell growth supplement and 1% penicillin/streptomycin solution (ScienCell TM , ECM, Cat. No. 1001). The cells were propagated until approximate 90% confluence, followed by passaging using 0.25% trypsin-EDTA solution (Invitrogen, Karlsruhe, Germany; cat. 25, 200) accoding to published protocols (Bauwens et al. 2011; Betz et al. 2011 Betz et al. , 2012 . pHRGECs of the fourth passage were deposited in an institutional master bank and stored at -192°C in the gas phase over liquid nitrogen. The morphology and growth characteristics of pHRGECs were examined microscopically with respect to evidence of senescence or dedifferentiation, which might occur as a consequence of long time cultivation of primary cells, as photographically documented in the Supplementary data, Figure S1 . The primary cells were at all times inspected using an Axiovert 40 C microsocope (Carl Zeiss AG, Oberkochen, Germany). Furthermore, cells were monitored with a digital camera (Canon PowerShot G10, Canon, Tokyo, Japan), documented with AxioVison 4.8 (Carl Zeiss AG) and data were processed using Adobe Photoshop software (Adobe Systems, San Jose, CA). 
D-PDMP
Stx1a and Stx2a
Stx-subtypes Stx1a and Stx2a, referred to as Stx1 and Stx2 in previous publications and now renamed as Stx1a and Stx2a, respectively, according to the suggestions of Scheutz et al. (2012) were purified from E. coli C600(H19J) carrying the stx 1 gene from E. coli O26: H11 strain H19 and from E. coli C600(933 W) carrying the stx 2 gene from E. coli O157:H7 strain EDL933 as previously described (Bauwens et al. 2011) . Structural integrity and purity of Stx1a and Stx2a were validated using SDS-PAGE and mass spectrometric peptide mapping (Müthing et al. 2009 ).
Lipid extraction and isolation of neutral GSLs
Total lipids were extracted from confluent endothelial cell layers, which were propagated in 175 cm 2 tissue culture flasks (Greiner Bio-One), with methanol as the primary isolation solvent (Betz et al. 2011; Storck et al. 2012; Legros et al. 2017 ). The methanolic suspension was centrifuged and the sediment was stepwise extracted with chloroform/methanol (1/2, v/v), chloroform/methanol (1/1, v/v) and chloroform/methanol (2/1, v/v). The supernatants were combined and rotary evaporated to dryness. In case of subsequent analysis of GSLs, which are stable toward mild alkaline hydrolysis, coextracted triglycerides and glycerophospholipids were disintegrated by mild saponification for 1 h in 1 N aqueous NaOH at 37°C. After dialysis and freeze drying, the extract was dissolved in chloroform/ methanol/water (30/60/8, each by vol) and neutral GSLs were isolated by anion-exchange chromatography on DEAE-Sepharose CL-6B (GE Healthcare, Munich, Germany) as described in earlier times (Müthing et al. 1987) . Finally, the neutral GSLs were taken up in a defined volume of chloroform/methanol (2/1, v/v) and stored at -20°C until use.
GSL, cholesterol and phospholipid references
A GSL mixture, which has been prepared from human erythrocytes and contains lactosylceramide (Lc2Cer, Galβ4Glcβ1Cer), Gb3Cer (Galα4Galβ4Glcβ1Cer) and Gb4Cer (GalNAcβ3Galα4Galβ4Glcβ1Cer), was employed as neutral GSL reference (R1) for orcinol stains and as positive control for the antibody and Stx TLC overlay assays (Meisen et al. 2005; Kouzel et al. 2013; Betz et al. 2016; Legros et al. 2017) . The nomenclature of the GSLs follows the IUPAC-IUB recommendations 1997 (Chester 1998) . Cholesterol (Sigma-Aldrich, Inc., St. Louis, MO, USA; Cat. No. C8667) was used as reference (R2) for cholesterol analysis Steil et al. 2015) . For phospholipid investigations, a reference mixture (R3) harboring phosphatidylglycerol (PG), phosphatidylethanolamine (PE), phosphatidic acid (PA), lyso-PE, phosphatidylcholine (PC) and sphingomyelin (SM) was employed as previously described Steil et al. 2015; Legros et al. 2017 ).
High-performance thin-layer chromatography
GSLs and phospholipids were applied to glass-backed plates coated with silica gel 60 (HPTLC plates, size 10 cm × 10 cm, thickness 0.2 mm, no. 1.05633.0001; Merck, Darmstadt, Germany) using an automatic sample applicator (Linomat 5, Camag, Muttenz, Switzerland). GSLs were separated in chloroform/methanol/water (120/70/17, each by volume) and stained with orcinol Steil et al. 2015; Legros et al. 2017) . Phospholipids were stained with molybdenum blue Dittmer-Lester reagent (Dittmer and Lester 1964; Müthing and Radloff 1998) after chromatography in chloroform/methanol/isopropanol/triethylamine/ 0.25% aqueous KCl (30/9/25/18/6, each by vol). Cholesterol was chromatographed in chloroform/aceton (96/4, v/v) and stained with manganese(II) chloride (Goswami and Frey 1970; Betz et al. 2011; Kouzel et al. 2013; Steil et al. 2015 ).
Anti-flotillin-2, anti-GSL, anti-Stx and secondary antibodies
The monoclonal rabbit anti-flotillin-2 antibody (C42A3, Cat. No. 3436) was purchased from Cell Signaling Technology, Inc.
(Danvers, MA) (Betz et al. 2011) . The specificities of chicken polyclonal IgY antibodies against Gb3Cer and Gb4Cer have been previously described Schweppe et al. 2010; Kouzel et al. 2013; Steil et al. 2015; Legros et al. 2017) . Mouse monoclonal anti-Stx1 (clone VT109/4-E9) and anti-Stx2 antibody (clone VT135/6-B9) were obtained from Sifin GmbH (Berlin, Germany) (Schweppe et al. 2010; Storck et al. 2012; Legros et al. 2017) . Alkaline phosphatase (AP)-conjugated goat anti-rabbit IgG (Code 111-055-003), goat anti-mouse IgG (Code 115-055-003), and rabbit anti-chicken IgY (Code 303-055-033) secondary antibodies were purchased from Dianova (Hamburg, Germany).
GSL detection using antibody and Stx TLC overlay assays
Chicken anti-Gb3Cer and anti-Gb4Cer antibodies as well as Stx1a and Stx2a (corresponding to Stx1 and Stx2, respectively, in former publications) were utilized for the detection of Stx-receptor GSLs in lipid extracts prepared from pHRGECs following previously published protocols (Schweppe et al. 2010; Betz et al. 2011; Storck et al. 2012; Kouzel et al. 2013; Steil et al. 2015) . In short, the silica gel layer of the TLC glass plate was fixed with 0.5% (w/v) polyisobutylmethacrylate (Plexigum P28, Röhm, Darmstadt, Germany) in dried hexane after chromatography. Immunodetection was performed with primary anti-Gb3Cer and anti-Gb4Cer antibodies together with secondary AP-conjugated anti-chicken IgY antibodies (both 1:2000 diluted). In addition, Stx-receptor GSLs were directly detected with Stx1a or Stx2a (0.2 μg/mL each) in conjunction with anti-Stx1 or anti-Stx2 antibodies (1:1000 dilution each) and APconjugated secondary anti-mouse IgG antibodies (1:2000 dilutions).
Bound antibodies were detected as blue precipitate using 0.05% (w/ v) 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP, Roth, Karlsruhe, Germany) in glycine buffer as enzyme substrate (Schweppe et al. 2010; Betz et al. 2011; Storck et al. 2012; Kouzel et al. 2013; Steil et al. 2015) .
Densitometric quantification of TLC-immunostained GSLs, cholesterol and phospholipids
The TLC-separated lipids were quantified densitometrically with a CD60 scanner (Desaga, Heidelberg, Germany, software ProQuant®, version 1.06.000) in reflectance mode with a light beam slit of 0.02 mm × 4 mm. Molybdenum blue-stained phospholipid, pink/ brown cholesterol and deep purpled orcinol bands were scanned at wavelengths of λ = 700 nm, λ = 365 nm and λ = 544 nm, respectively. BCIP-stained dark blue immunopositive GSL bands were densitometrically quantified at a wavelength of λ = 630 nm (Betz et al. 2011 (Betz et al. , 2012 Kouzel et al. 2013; Steil et al. 2015; Legros et al. 2017) . All scans were performed in triplicate with extracts from two independent cell culture approaches.
Preparation of sucrose density gradient DRM and nonDRM fractions DRM and nonDRM fractions, the latter further subdivided into intermediate and bottom fractions, were prepared following the protocol of Brown and Rose (Brown and Rose 1992) with minor changes as previously reported (Betz et al. 2011; Kouzel et al. 2013; Meisen et al. 2013; Steil et al. 2015; Legros et al. 2017) . Briefly, pHRGECs at confluence were solubilized in lysis buffer, residual cell debris was removed by gentle centrifugation (10 min, 4°C, 400 × g) and membranes were separated from the cytosol by short ultracentrifugation of the supernatant (30 min, 4°C, 150,000 × g). The membrane sediment was dissolved in 1 mL of 1% Triton X-100 buffer followed by mixing with 1 mL of 85% sucrose. The resulting 2 mL of 42.5% sucrose solution was then successively overlayed with 8 mL of 30% and 2 mL of 5% sucrose. After ultracentrifugation (19 h, 4°C, 200,000 × g), eight fractions of 1.5 mL each were collected top down of the gradient: three top DRM-associated fractions (F1-F3) and five nonDRM fractions (F4-F8), which were further subdivided into three intermediated fractions (F4-F6) and two bottom fractions (F7 and F8).
Isolation of proteins, GSLs and phospholipids from DRM and nonDRM fractions
A volume of 0.5 mL of each sucrose gradient fractions (that are three DRM and five nonDRM fractions) required for protein analysis was dialyzed against deionized water at 4°C for 2 days to remove sucrose and freeze dried. Proteins were precipitated with 5% (w/v) trichloroacetic acid, washed with absolute ethanol, and applied to SDS-PAGE followed by Western blotting (Betz et al. 2011; Kouzel et al. 2013; Legros et al. 2017 ). An aliquot of 0.5 mL of each fraction, used for the phospholipid analysis, was dialyzed, freeze dried, solubilized with supporting short sonication in chloroform/methanol (2/1, v/v). For GSL analysis, 0.5 mL aliquots of each gradient fraction (after dialysis and lyphilisation) were submitted to alkaline treatment in aqueous 1 N NaOH for 1 h at 37°C under gentle rotation to saponify glycerophospholipids and triglycerides, followed by neutralization with HCl (Betz et al. 2011; Kouzel et al. 2013; Legros et al. 2017) . After dialysis and freeze drying the extracts were dissolved in chloroform/methanol (2/1, v/v) and adjusted to a defined concentration.
SDS-PAGE and western blotting
Proteins of sucrose gradient fractions were precipitated and electrophoretically separated by SDS-PAGE as previously described (Betz et al. 2011; Kouzel et al. 2013; Legros et al. 2017 ). Proteins were transferred by semi-dry blotting onto nitrocellulose, followed by overlaying the membrane with anti-flotillin-2 antibody (diluted 1:4000) and incubation with AP-conjugated anti-rabbit IgG secondary antibody (diluted 1:2000) . Bound antibodies were detected with nitroblue tetrazolium (NBT)/BCIP kit (Invitrogen).
Mass spectrometry
Mass spectrometry analysis of GSLs was performed by nano electrospray ionization mass spectrometry (nanoESI MS) on a quadrupole time-of-flight mass spectrometer equipped with a nanospray manipulator (Micromass, Manchester, UK) in the positive ion mode as described previously Legros et al. 2017) . Dried aliquots of GSL preparations were resolved in 1% (v/v) formic acid in methanol and submitted to MS 1 analysis. Proposed GSL structures were confirmed using low energy collision-induced dissociation (CID) experiments (MS 2 ). For this purpose, precursor ions were selected in the quadrupole analyzer and fragmented in the collision cell using a collision gas (Ar) pressure of 3.0 × 10 -3 Pa and collision energies of 20-40 eV (E lab ). Dried phospholipids of DRM fraction F2 and nonDRM bottom fraction F7 were dissolved in methanol and analyzed in the positive ion sensitivity mode by nanoESI MS using a SYNAPT G2-S mass spectrometer (Waters, Manchester, UK) equipped with a Z-spray source (Steil et al. 2016) . The source settings were: temperature 80°C, capillary voltage 0.8 kV, sampling cone voltage 20 V, and offset voltage 50 V. For CID measurements, the lipid precursor ions were selected in the quadrupole analyzer and ion mobility separation was employed (wave velocity 700-800 m/s, wave height 40 V, nitrogen gas flow rate 90 mL/min, helium gas flow rate 180 mL/min). CID was performed in the transfer cell with a collision gas (Ar) flow rate of 2.0 mL/min and collision energies up to 100 eV (E lab ). Structures of individual phospholipids were deduced from CID spectra.
Supplementary data
Supplementary data is available at Glycobiology online.
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